Opis projekta
The main goal of the proposed project is to identify new drug targets and accordingly design, prepare and characterise new drugs for Helicobacter pylori eradication. Helicobacter pylori is a bacterium that colonizes one half of the world population and it is regarded as one of the most invasive human pathogens responsible for development of many diseases. There are two possible pathways that organisms can use to synthesize purines as indispensable building blocks for DNA and RNA synthesis. However, bacterium H. pylori uses the salvage pathway, only. Therefore, we plan to disable H. pylori growth and replication by inhibiting the key enzymes, purine nucleoside phosphorylase and adenylosuccinate synthetase, on this pathway. The proposed project includes the interdisciplinary team with expertise in the research areas of molecular biology and genetics, biochemistry and biophysics, macromolecular crystallography, biological mass spectrometry, molecular modelling, organic synthesis, analytical ultracentrifugation methods, susceptibility testing, and managing ‘big data’ through data integration (extracted from various databases). All equipment necessary to accomplish the proposed research is available in the host institution (Rudjer Bošković Institute) except for analytical ultracentrifuge available by foreign co-worker A. Bzowska (Warsaw, Poland).
Akronim
PSPE
Šifra projekta
IP-2013-11-7423
Poziv
2013-11
Vrsta projekta
Znanstveno-istraživački
Vrsta financiranja
Kompetitivno projektno financiranje
Financijer
HRZZ - Hrvatska zaklada za znanost
Detalji financiranja
IP - Istraživački projekti
Ukupan iznos financiranja projekta
921.235,00 HRK
Trajanje projekta
01-09-2014 - 31-08-2018
Ustanova - uloga
Institut "Ruđer Bošković", Zagreb - Nositelj (921.235,00 HRK) [01-09-2014 - 31-08-2018]
Osoba - Ustanova - uloga [pocetak - zavrsetak]
Marija Luić
(MBZ: 77430,
CROSBI: 20136) - Institut "Ruđer Bošković", Zagreb - Voditelj projekta [01-09-2014 - 31-08-2018]
